|
|
|
PROTEIN KINASE A (PKA) SIGNALING PATHWAY (PW:0000543)
DescriptionProtein
kinase A (PKA) signaling is a widely used intracellular pathway and the major route for channeling the second messenger cAMP signal.
Ligand activated G-protein coupled receptors that transduce the signal via the
Gs alpha subunit of the heterotrimeric G protein lead to activation of the adenylyl
cyclase enzymes (AC) that catalyze the formation of cAMP from ATP. GTP-bound Gs
binds to AC and increases the affinity between the C1 and C2 cytoplasmic
domains whose interface constitutes the ATP binding site. Nine membrane-bound
and one soluble adenylyl cyclase have been so far identified. Most tissues
express more than one AC and almost every AC is expressed in the brain. cAMP
binding to the PKA complex leads to dissociation of the catalytic subunits from
the holoenzyme. In the inactive state, the holoenzyme consists of two catalytic
subunits (C) bound noncovalently to a regulatory dimer (RI or RII). There are two
type I and two type II regulatory subunits and three catalytic subunits in
humans; rodents express only two catalytic subunits. Each regulatory subunit
has two cAMP binding sites; type I has a higher affinity for cAMP than type II.
Binding of four molecules of cAMP to the regulatory dimer induces a
conformational change that leads to dissociation of the holoenzyme and release
of the catalytic monomers. cAMP is hydrolyzed by phosphodiesterases (PDE), the
only enzymes degrading cycling nucleotides. The 21 mammalian genes are
subdivided in 11 families based on kinetic and pharmacological properties. Of these,
3 families are specific for cAMP, 3 other for cGMP and 5 hydrolyze both. PDEs not
only contribute to the regulation of cAMP concentration but also modulate the
duration and extent of cAMP signaling, and thus of PKA. The compartmentalization
of PKA is mediated by the AKAP family of scaffold proteins ( A Kinase
Anchoring Protein). AKAPs bring together PKA (and other kinases)
along with phosphatases and phosphodiesterases, in some cases AC and target
proteins to fine tune the many outcomes of PKA signaling. 14 Akap genes in
mammals give rise to more than 50 proteins. Primarily they target the regulatory
type II subunits; a few possess dual specificity and bind both subunits types.
The various combinations of AKAP-PKA allow for the diversity of cellular and
tissue distribution of the serine/threonine PKA complexes and the modulation of
their function and underlie the extensive use of this intracellular pathway.
PKA cross-talks or integrates with other signaling pathways. The PKA signaling
pathway has been implicated in many cellular and physiological processes, from
metabolism and reproduction, to cardiac function, memory and learning. To see the ontology report for annotations,
GViewer and download click here [click to see the ontology report for related GO
term GO:0010737 and entry at Reactome - REACT_15530.1]...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
protein kinase A (PKA) signaling pathway
|
| G |
Adcy1 |
adenylate cyclase 1 (brain) |
|
|
ISS |
14 |
87,812,256 |
87,923,402 |
RGD:2312469 |
RGD |
| G |
Adcy10 |
adenylate cyclase 10 (soluble) |
|
|
ISS |
13 |
81,208,090 |
81,302,902 |
RGD:2312469 |
RGD |
| G |
Adcy2 |
adenylate cyclase 2 (brain) |
|
|
ISS |
17 |
4,543,466 |
5,040,433 |
RGD:2312469 |
RGD |
| G |
Adcy3 |
adenylate cyclase 3 |
|
|
ISS |
6 |
27,118,325 |
27,202,275 |
RGD:2312469 |
RGD |
| G |
Adcy4 |
adenylate cyclase 4 |
|
|
ISS |
15 |
33,930,531 |
33,946,352 |
RGD:2312469 |
RGD |
| G |
Adcy5 |
adenylate cyclase 5 |
|
|
ISS |
11 |
67,290,968 |
67,437,468 |
RGD:2312469 |
RGD |
| G |
Adcy6 |
adenylate cyclase 6 |
|
|
IDA |
7 |
137,339,933 |
137,360,020 |
RGD:2313211 |
RGD |
| G |
Adcy6 |
adenylate cyclase 6 |
|
|
ISS |
7 |
137,339,933 |
137,360,020 |
RGD:2312469 |
RGD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
|
ISS |
19 |
20,051,639 |
20,073,861 |
RGD:2312469 |
RGD |
| G |
Adcy8 |
adenylate cyclase 8 (brain) |
|
|
ISS |
7 |
101,957,807 |
102,210,346 |
RGD:2312469 |
RGD |
| G |
Adcy9 |
adenylate cyclase 9 |
|
|
ISS |
|
|
|
RGD:2312469 |
RGD |
| G |
Akap1 |
A kinase (PRKA) anchor protein 1 |
|
|
ISS |
10 |
77,262,592 |
77,276,832 |
RGD:2312475 |
RGD |
| G |
Akap1 |
A kinase (PRKA) anchor protein 1 |
|
|
ISS |
10 |
77,262,592 |
77,276,832 |
RGD:2312477 |
RGD |
| G |
Akap10 |
A kinase (PRKA) anchor protein 10 |
|
|
ISS |
10 |
48,031,107 |
48,087,922 |
RGD:2312475 |
RGD |
| G |
Akap10 |
A kinase (PRKA) anchor protein 10 |
|
|
ISS |
10 |
48,031,107 |
48,087,922 |
RGD:2312477 |
RGD |
| G |
Akap11 |
A kinase (PRKA) anchor protein 11 |
|
|
IMP |
15 |
59,649,461 |
59,679,551 |
RGD:2312637 |
RGD |
| G |
Akap11 |
A kinase (PRKA) anchor protein 11 |
|
|
ISS |
15 |
59,649,461 |
59,679,551 |
RGD:2312475 |
RGD |
| G |
Akap11 |
A kinase (PRKA) anchor protein 11 |
|
|
ISS |
15 |
59,649,461 |
59,679,551 |
RGD:2312477 |
RGD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
|
ISS |
1 |
34,979,039 |
35,068,763 |
RGD:2312475 |
RGD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
|
ISS |
1 |
34,979,039 |
35,068,763 |
RGD:2312477 |
RGD |
| G |
Akap13 |
A kinase (PRKA) anchor protein 13 |
|
|
ISS |
1 |
131,052,674 |
131,360,512 |
RGD:2312475 |
RGD |
| G |
Akap13 |
A kinase (PRKA) anchor protein 13 |
|
|
ISS |
1 |
131,052,674 |
131,360,512 |
RGD:2312477 |
RGD |
| G |
Akap14 |
A kinase (PRKA) anchor protein 14 |
|
|
ISS |
X |
7,744,305 |
7,759,380 |
RGD:2312477 |
RGD |
| G |
Akap14 |
A kinase (PRKA) anchor protein 14 |
|
|
ISS |
X |
7,744,305 |
7,759,380 |
RGD:2312475 |
RGD |
| G |
Akap2 |
A kinase (PRKA) anchor protein 2 |
|
|
ISS |
5 |
75,814,965 |
75,855,492 |
RGD:2312475 |
RGD |
| G |
Akap2 |
A kinase (PRKA) anchor protein 2 |
|
|
ISS |
5 |
75,814,965 |
75,855,492 |
RGD:2312477 |
RGD |
| G |
Akap3 |
A kinase (PRKA) anchor protein 3 |
|
|
ISS |
4 |
163,241,422 |
163,263,433 |
RGD:2312475 |
RGD |
| G |
Akap3 |
A kinase (PRKA) anchor protein 3 |
|
|
ISS |
4 |
163,241,422 |
163,263,433 |
RGD:2312477 |
RGD |
| G |
Akap4 |
A kinase (PRKA) anchor protein 4 |
|
|
ISS |
X |
27,515,009 |
27,524,606 |
RGD:2312475 |
RGD |
| G |
Akap4 |
A kinase (PRKA) anchor protein 4 |
|
|
ISS |
X |
27,515,009 |
27,524,606 |
RGD:2312477 |
RGD |
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
|
ISS |
6 |
98,923,105 |
98,928,505 |
RGD:2312475 |
RGD |
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
|
ISS |
6 |
98,923,105 |
98,928,505 |
RGD:2312477 |
RGD |
| G |
Akap6 |
A kinase (PRKA) anchor protein 6 |
|
|
IMP |
6 |
73,010,779 |
73,354,520 |
RGD:68716 |
RGD |
| G |
Akap6 |
A kinase (PRKA) anchor protein 6 |
|
|
ISS |
6 |
73,010,779 |
73,354,520 |
RGD:2312475 |
RGD |
| G |
Akap6 |
A kinase (PRKA) anchor protein 6 |
|
|
ISS |
6 |
73,010,779 |
73,354,520 |
RGD:2312477 |
RGD |
| G |
Akap7 |
A kinase (PRKA) anchor protein 7 |
|
|
ISS |
1 |
20,573,215 |
20,704,564 |
RGD:2312475 |
RGD |
| G |
Akap7 |
A kinase (PRKA) anchor protein 7 |
|
|
ISS |
1 |
20,573,215 |
20,704,564 |
RGD:2312477 |
RGD |
| G |
Akap7 |
A kinase (PRKA) anchor protein 7 |
|
|
IMP |
1 |
20,573,215 |
20,704,564 |
RGD:2312630 |
RGD |
| G |
Akap8 |
A kinase (PRKA) anchor protein 8 |
|
|
ISS |
7 |
12,873,303 |
12,889,333 |
RGD:2312475 |
RGD |
| G |
Akap8 |
A kinase (PRKA) anchor protein 8 |
|
|
ISS |
7 |
12,873,303 |
12,889,333 |
RGD:2312477 |
RGD |
| G |
Akap9 |
A kinase (PRKA) anchor protein (yotiao) 9 |
|
|
ISS |
4 |
26,772,929 |
26,803,149 |
RGD:2312475 |
RGD |
| G |
Akap9 |
A kinase (PRKA) anchor protein (yotiao) 9 |
|
|
ISS |
4 |
26,772,929 |
26,803,149 |
RGD:2312477 |
RGD |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
|
IMP |
4 |
83,839,822 |
83,867,017 |
RGD:5131271 |
RGD |
| G |
Ezr |
ezrin |
|
|
ISS |
1 |
41,178,195 |
41,221,735 |
RGD:2312475 |
RGD |
| G |
Pde10a |
phosphodiesterase 10A |
|
|
ISS |
1 |
46,392,900 |
46,589,076 |
RGD:2312479 |
RGD |
| G |
Pde11a |
phosphodiesterase 11A |
|
|
ISS |
3 |
58,659,595 |
59,049,869 |
RGD:2312479 |
RGD |
| G |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
|
|
ISS |
3 |
62,650,092 |
62,928,487 |
RGD:2312479 |
RGD |
| G |
Pde1b |
phosphodiesterase 1B, calmodulin-dependent |
|
|
ISS |
7 |
142,401,489 |
142,427,626 |
RGD:2312479 |
RGD |
| G |
Pde1c |
phosphodiesterase 1C |
|
|
ISS |
4 |
84,936,642 |
85,448,339 |
RGD:2312479 |
RGD |
| G |
Pde2a |
phosphodiesterase 2A, cGMP-stimulated |
|
|
ISS |
1 |
158,921,607 |
159,013,829 |
RGD:2312479 |
RGD |
| G |
Pde3a |
phosphodiesterase 3A, cGMP inhibited |
|
|
ISS |
4 |
178,658,896 |
178,930,417 |
RGD:2312479 |
RGD |
| G |
Pde3a |
phosphodiesterase 3A, cGMP inhibited |
|
|
ISS |
4 |
178,658,896 |
178,930,417 |
RGD:2312479 |
RGD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
|
ISS |
1 |
172,409,282 |
172,577,108 |
RGD:2312479 |
RGD |
| G |
Pde4a |
phosphodiesterase 4A, cAMP-specific |
|
|
ISS |
8 |
20,192,677 |
20,241,557 |
RGD:2312479 |
RGD |
| G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
|
|
ISS |
5 |
123,158,156 |
123,533,877 |
RGD:2312479 |
RGD |
| G |
Pde4c |
phosphodiesterase 4C, cAMP-specific |
|
|
ISS |
16 |
19,197,277 |
19,215,627 |
RGD:2312479 |
RGD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP-specific |
|
|
ISS |
2 |
40,196,097 |
41,311,012 |
RGD:2312479 |
RGD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP-specific |
|
|
IMP |
2 |
40,196,097 |
41,311,012 |
RGD:68716 |
RGD |
| G |
Pde7a |
phosphodiesterase 7A |
|
|
ISS |
2 |
104,339,910 |
104,429,820 |
RGD:2312479 |
RGD |
| G |
Pde7b |
phosphodiesterase 7B |
|
|
ISS |
1 |
15,701,127 |
15,929,632 |
RGD:2312479 |
RGD |
| G |
Pde8a |
phosphodiesterase 8A |
|
|
ISS |
1 |
137,415,852 |
137,544,337 |
RGD:2312479 |
RGD |
| G |
Pde8b |
phosphodiesterase 8B |
|
|
ISS |
2 |
25,352,725 |
25,469,209 |
RGD:2312479 |
RGD |
| G |
Prkaca |
protein kinase, cAMP-dependent, catalytic, alpha |
|
|
ISS |
19 |
25,840,795 |
25,864,786 |
RGD:2312475 |
RGD |
| G |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
|
|
ISS |
2 |
244,949,303 |
245,035,266 |
RGD:2312475 |
RGD |
| G |
Prkar1a |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
|
|
ISS |
10 |
148,642,200 |
148,642,454 |
RGD:2312475 |
RGD |
| G |
Prkar1b |
protein kinase, cAMP dependent regulatory, type I, beta |
|
|
ISS |
12 |
16,025,867 |
16,131,129 |
RGD:2312475 |
RGD |
| G |
Prkar2a |
protein kinase, cAMP dependent regulatory, type II alpha |
|
|
ISS |
8 |
113,746,384 |
113,805,476 |
RGD:2312475 |
RGD |
| G |
Prkar2b |
protein kinase, cAMP dependent regulatory, type II beta |
|
|
ISS |
6 |
50,234,979 |
50,325,298 |
RGD:2312475 |
RGD |
|
|
|
Pathway Gene Annotations |
|
Disease Annotations Associated with Genes in the protein kinase A (PKA) signaling pathway
|
|
|
|
|
|
|
| Adcy3 | Infertility, Female , Olfaction Disorders | |
|
|
|
|
|
| Akap10 | Cardiac Conduction Defect | |
|
|
|
| Akap1 | Brain Ischemia | |
|
| Akap4 | Infertility, Male | | Akap5 | Alzheimer Disease , Cardiomegaly , Tetany | |
|
|
| Akap9 | Long QT Syndrome , Long Qt Syndrome 11 | | Crhr2 | Anorexia , Asthma , Colitis , Colonic Diseases, Functional , Depressive Disorder , Fetal Hypoxia , Hypertrophy, Left Ventricular , Hypotension , Irritable Bowel Syndrome , Ischemia , Muscular Atrophy , Pneumonia , Pneumonia, Pneumococcal , Rhinitis | |
|
| Pde11a | Pigmented Nodular Adrenocortical Disease, Primary, 2 | |
|
|
|
| Pde3a | Diabetes Mellitus, Experimental , Hypertension, Pulmonary , Insulin Resistance | |
| Pde4a | Brucellosis , Seizures | |
|
| Pde4d | Stroke | |
|
|
| Pde8b | Adrenal Hyperplasia, Congenital , Striatal Degeneration, Autosomal Dominant | | Prkaca | Cardiomyopathy, Hypertrophic , Heart Failure | |
| Prkar1a | Atrial myxoma, familial , Carney Complex , Cushing Syndrome , Myxoma , Pigmented Nodular Adrenocortical Disease, Primary, 1 , Thyroid cancer, papillary | | Prkar1b | Hypertension | | Prkar2a | Heart Failure | | Prkar2b | Granulosa Cell Tumor | |
| Brucellosis | Pde4a | | Ischemia | Crhr2 | | Seizures | Pde4a | | Granulosa Cell Tumor | Prkar2b | | Cardiomegaly | Akap5 | | Myxoma | Prkar1a | | Hypertension, Pulmonary | Pde3a | | Olfaction Disorders | Adcy3 | | Colitis | Crhr2 | | Cardiomyopathy, Hypertrophic | Prkaca | | Pneumonia | Crhr2 | | Adrenal Hyperplasia, Congenital | Pde8b | | Rhinitis | Crhr2 | | Anorexia | Crhr2 | | Muscular Atrophy | Crhr2 | | Alzheimer Disease | Akap5 | | Thyroid cancer, papillary | Prkar1a | | Long QT Syndrome | Akap9 | | Hypertension | Prkar1b | | Infertility, Male | Akap4 | | Insulin Resistance | Pde3a | | Atrial myxoma, familial | Prkar1a | | Asthma | Crhr2 | | Brain Ischemia | Akap1 | | Colonic Diseases, Functional | Crhr2 | | Cushing Syndrome | Prkar1a | | Depressive Disorder | Crhr2 | | Diabetes Mellitus, Experimental | Pde3a | | Heart Failure | Prkaca , Prkar2a | | Fetal Hypoxia | Crhr2 | | Hypotension | Crhr2 | | Infertility, Female | Adcy3 | | Pneumonia, Pneumococcal | Crhr2 | | Tetany | Akap5 | | Hypertrophy, Left Ventricular | Crhr2 | | Stroke | Pde4d | | Irritable Bowel Syndrome | Crhr2 | | Carney Complex | Prkar1a | | Cardiac Conduction Defect | Akap10 | | Striatal Degeneration, Autosomal Dominant | Pde8b | | Pigmented Nodular Adrenocortical Disease, Primary, 1 | Prkar1a | | Pigmented Nodular Adrenocortical Disease, Primary, 2 | Pde11a | | Long Qt Syndrome 11 | Akap9 | |
|